GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET

7.1 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)

8.1 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

8.2 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

9.1 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

9.2 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

10.1 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)

10.2 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)

11.1 NORTH AMERICA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

11.2 NORTH AMERICA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

11.3 NORTH AMERICA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

11.4 NORTH AMERICA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

11.5 NORTH AMERICA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

11.6 NORTH AMERICA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

12.1 EUROPE GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

12.2 EUROPE GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

12.3 EUROPE GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

12.4 EUROPE GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

12.5 EUROPE GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

12.6 EUROPE GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

13.1 ASIA PACIFIC GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

13.2 ASIA PACIFIC GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

13.3 ASIA PACIFIC GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

13.4 ASIA PACIFIC GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

13.5 ASIA PACIFIC GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

13.6 ASIA PACIFIC GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

14.1 LATIN AMERICA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>

14.2 LATIN AMERICA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

14.3 LATIN AMERICA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

14.4 LATIN AMERICA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

14.5 LATIN AMERICA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

14.6 LATIN AMERICA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>

16.1 Ariad Pharmaceuticals Inc

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Arog Pharmaceuticals Inc

16.3 Array BioPharma Inc

16.4 Astex Pharmaceuticals Inc

16.5 Blueprint Medicines Corporation

16.6 Boston Biomedical Inc

16.7 Calithera Biosciences Inc

16.8 Chipscreen Biosciences Ltd

16.9 Deciphera Ph

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER